A CLINICAL REVIEW ON: HYPOKALEMIC PERIODIC PARALYSIS-DIAGNOSIS AND TREATMENT

Journal Title: World Journal of Pharmaceutical and life sciences - Year 2017, Vol 3, Issue 9

Abstract

Hypokalemic periodic paralysis is a rare, autosomal dominant channelopathy characterized by muscle weakness or paralysis with a matching fall in potassium levels in the blood (primarily due to defect in a voltage-gated calcium channel). In individuals with this mutation, attacks often begin in adolescence and most commonly occur on awakening or after sleep or rest following strenuous exercise (attacks during exercise are rare), high carbohydrate meals, meals with high sodium content, sudden changes in temperature, and even excitement, noise, flashing lights and induced by cold temperatures. Weakness may be mild and limited to certain muscle groups, or more severe full body paralysis. Attacks may last for a few hours or persist for several days. Recovery is usually sudden when it occurs, due to release of potassium from swollen muscles as they recover. Some patients may fall into an abortive attack or develop chronic muscle weakness later in life. Diagnosis can be achieved through a specialized form of electromyographic (EMG) testing called the long exercise test. This test measures the amplitude of a nerve response (called the Compound Muscle Action Potential or CMAP) for 40 to 50 minutes following a few minutes of exercise. Treatment of hypokalemic periodic paralysis focuses on preventing further attacks and relieving acute symptoms. Avoiding carbohydrate-rich meals, strenuous exercise and other identified triggers, and taking acetazolamide (Diamox) or another carbonic anhydrase inhibitor, may help prevent attacks of weakness. Some patients also take potassium-sparing diuretics such as spironolactone to help maintain potassium levels.

Authors and Affiliations

Matsyagiri Lenkalapally

Keywords

Related Articles

DIFFERENT BIOLOGICAL ACTIVITIES OF SUBSTITUTED BENZIMIDAZOLE DERIVATIVES-A REVIEW ARTICLE

Benzimidazole and its derivatives are considered as an important heterocyclic compound that exhibits a wide range of pharmaceutical applications including anti-cancers, anti-microbial, anti-hypertensive, anti-viral, anti...

A REVIEW ON PLANT ORIGIN ANTICANCER DRUGS

Globally cancer is a disease which severely effects the human population. There is a constant demand for new therapies to treat and prevent this life-threatening disease. Scientific and research interest is drawing its a...

ONCOGENICITY OF TOBACCO-SMOKING: A REVIEW ON SQUAMOUS CELL CARCINOMA OF THE TONGUE, DIAGNOSIS AND TREATMENT

Squamous cell carcinoma (SCC) of the tongue is the commonest type of tongue cancer affecting young smokers and older men (over 45 years of age) than women. It represents more than ninety percent of all head and neck canc...

ROUTINE POST OPERATIVE ANTIBIOTIC PROPHYLAXIS IS UNNECESSARY TO PREVENT PORT SITE INFECTION IN ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY FOR LOW RISK GALL STONE DISEASE: A PROSPECTIVE RANDOMIZED CLINICAL TRIAL

Background: Cholecystitis is a global phenomenon prevailing more or less all over the world. One of the causes of increased morbidity after laparoscopic cholecystectomy has been port site infection. This study was carrie...

ROLE OF VAMAN IN YUVAN PIDIKA

Face is the mirror of the individual personality & any least mark can results into a larger impact on the individual whole beauty of the body depends upon the beauty of the face. Minor problems as leads to non-attractive...

Download PDF file
  • EP ID EP649590
  • DOI -
  • Views 156
  • Downloads 0

How To Cite

Matsyagiri Lenkalapally (2017). A CLINICAL REVIEW ON: HYPOKALEMIC PERIODIC PARALYSIS-DIAGNOSIS AND TREATMENT. World Journal of Pharmaceutical and life sciences, 3(9), 101-107. https://europub.co.uk/articles/-A-649590